Applying next-generation sequencing to predict short progression-free survival in patients with advanced EGFR -mutant lung adenocarcinoma receiving epidermal growth factor receptor tyrosine kinase inhibitors.
Saved in:
| Title: | Applying next-generation sequencing to predict short progression-free survival in patients with advanced EGFR -mutant lung adenocarcinoma receiving epidermal growth factor receptor tyrosine kinase inhibitors. |
|---|---|
| Authors: | Lee PH; Department of Chest Medicine, Taichung Veterans General Hospital, Taichung.; School of Medicine, National Yang Ming Chiao Tung University, Taipei.; Doctoral Program in Translational Medicine.; Rong Hsing Translational Medicine Research Center, National Chung Hsing University.; Lung Cancer Comprehensive Care and Research Center, Taichung Veterans General Hospital., Hsiao YC; Department of Chest Medicine, Taichung Veterans General Hospital, Taichung., Huang YH; Department of Chest Medicine, Taichung Veterans General Hospital, Taichung.; School of Medicine, National Yang Ming Chiao Tung University, Taipei.; Lung Cancer Comprehensive Care and Research Center, Taichung Veterans General Hospital.; Institute of Biomedical Sciences., Hsu KH; Department of Chest Medicine, Taichung Veterans General Hospital, Taichung.; Lung Cancer Comprehensive Care and Research Center, Taichung Veterans General Hospital., Tseng JS; Department of Chest Medicine, Taichung Veterans General Hospital, Taichung.; School of Medicine, National Yang Ming Chiao Tung University, Taipei.; Lung Cancer Comprehensive Care and Research Center, Taichung Veterans General Hospital.; Institute of Biomedical Sciences.; Department of Post-Baccalaureate Medicine, College of Medicine., Lin H; Department of Life Sciences, National Chung Hsing University., Chang GC; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital.; School of Medicine.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan., Yang TY; Department of Chest Medicine, Taichung Veterans General Hospital, Taichung.; Doctoral Program in Translational Medicine.; Rong Hsing Translational Medicine Research Center, National Chung Hsing University.; Lung Cancer Comprehensive Care and Research Center, Taichung Veterans General Hospital. |
| Source: | Anti-cancer drugs [Anticancer Drugs] 2025 Nov 01; Vol. 36 (10), pp. 839-845. Date of Electronic Publication: 2025 Aug 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40773366 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Applying next-generation sequencing to predict short progression-free survival in patients with advanced EGFR -mutant lung adenocarcinoma receiving epidermal growth factor receptor tyrosine kinase inhibitors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lee+PH%22">Lee PH</searchLink>; Department of Chest Medicine, Taichung Veterans General Hospital, Taichung.; School of Medicine, National Yang Ming Chiao Tung University, Taipei.; Doctoral Program in Translational Medicine.; Rong Hsing Translational Medicine Research Center, National Chung Hsing University.; Lung Cancer Comprehensive Care and Research Center, Taichung Veterans General Hospital.<br /><searchLink fieldCode="AU" term="%22Hsiao+YC%22">Hsiao YC</searchLink>; Department of Chest Medicine, Taichung Veterans General Hospital, Taichung.<br /><searchLink fieldCode="AU" term="%22Huang+YH%22">Huang YH</searchLink>; Department of Chest Medicine, Taichung Veterans General Hospital, Taichung.; School of Medicine, National Yang Ming Chiao Tung University, Taipei.; Lung Cancer Comprehensive Care and Research Center, Taichung Veterans General Hospital.; Institute of Biomedical Sciences.<br /><searchLink fieldCode="AU" term="%22Hsu+KH%22">Hsu KH</searchLink>; Department of Chest Medicine, Taichung Veterans General Hospital, Taichung.; Lung Cancer Comprehensive Care and Research Center, Taichung Veterans General Hospital.<br /><searchLink fieldCode="AU" term="%22Tseng+JS%22">Tseng JS</searchLink>; Department of Chest Medicine, Taichung Veterans General Hospital, Taichung.; School of Medicine, National Yang Ming Chiao Tung University, Taipei.; Lung Cancer Comprehensive Care and Research Center, Taichung Veterans General Hospital.; Institute of Biomedical Sciences.; Department of Post-Baccalaureate Medicine, College of Medicine.<br /><searchLink fieldCode="AU" term="%22Lin+H%22">Lin H</searchLink>; Department of Life Sciences, National Chung Hsing University.<br /><searchLink fieldCode="AU" term="%22Chang+GC%22">Chang GC</searchLink>; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital.; School of Medicine.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yang+TY%22">Yang TY</searchLink>; Department of Chest Medicine, Taichung Veterans General Hospital, Taichung.; Doctoral Program in Translational Medicine.; Rong Hsing Translational Medicine Research Center, National Chung Hsing University.; Lung Cancer Comprehensive Care and Research Center, Taichung Veterans General Hospital. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229100823%22">Anti-cancer drugs</searchLink> [Anticancer Drugs] 2025 Nov 01; Vol. 36 (10), pp. 839-845. <i>Date of Electronic Publication: </i>2025 Aug 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9100823 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1473-5741 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209594973%22">09594973 </searchLink><i>NLM ISO Abbreviation: </i>Anticancer Drugs <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40773366 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/CAD.0000000000001762 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 839 Titles: – TitleFull: Applying next-generation sequencing to predict short progression-free survival in patients with advanced EGFR -mutant lung adenocarcinoma receiving epidermal growth factor receptor tyrosine kinase inhibitors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lee PH – PersonEntity: Name: NameFull: Hsiao YC – PersonEntity: Name: NameFull: Huang YH – PersonEntity: Name: NameFull: Hsu KH – PersonEntity: Name: NameFull: Tseng JS – PersonEntity: Name: NameFull: Lin H – PersonEntity: Name: NameFull: Chang GC – PersonEntity: Name: NameFull: Yang TY IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2025 Nov 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1473-5741 Numbering: – Type: volume Value: 36 – Type: issue Value: 10 Titles: – TitleFull: Anti-cancer drugs Type: main |
| ResultId | 1 |
